{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the invention embodied in U.S. Patent 6,630,507, entitled \"Cannabinoids as antioxidants and neuroprotectants\" and PCT Application Serial No. PCT/US99/08769 and foreign equivalents thereof, entitled \"Cannabinoids as antioxidants and neuroprotectants\" [HHS Ref. No. E-287-1997/2] to KannaLife Sciences Inc., which has offices in New York, U.S. This patent and its foreign counterparts have been assigned to the Government of the United States of America. The prospective exclusive license territory may be worldwide, and the field of use may be limited to:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2011/11/17/2011-29726.html","cfr_references":[],"citation":"76 FR 71351","comment_url":null,"comments_close_on":"2011-12-19","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before December 19, 2011 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2011-29726","effective_on":null,"end_page":71351,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2011/11/17/2011-29726.xml","html_url":"https://www.federalregister.gov/documents/2011/11/17/2011-29726/prospective-grant-of-exclusive-license-development-of-cannabinoids-and-cannabidiols-based","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2011-29726?publication_date=2011-11-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2011-11-17/2011-29726/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":3344,"last_updated":"2026-11-22 06:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2011-11-17/pdf/2011-29726.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2011-29726.pdf?1321451833","publication_date":"2011-11-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2011/11/17/2011-29726.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2011-12-07T08:10:09Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":71351,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics To Treat Hepatic Encephalopathy in Humans.","toc_doc":"Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics to Treat Hepatic Encephalopathy in Humans","toc_subject":"Prospective Grants of Exclusive Licenses:","topics":[],"type":"Notice","volume":76}